Recombinant factor VIIa enhances deposition of platelets with congenital or acquired αIIBβ3 deficiency to endothelial cell matrix and collagen under conditions of flow via tissue factor-independent thrombin generation

被引:88
作者
Lisman, T
Moschatsis, S
Adelmeijer, J
Nieuwenhuis, HK
De Groot, PG
机构
[1] Univ Utrecht, Inst Biomembranes, Utrecht, Netherlands
[2] Univ Med Ctr, Dept Hematol, Thrombosis & Haemostasis Lab, Utrecht, Netherlands
关键词
D O I
10.1182/blood-2002-09-2761
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A novel approach to treat bleeding episodes in patients with Glanzmann thrombasthenia (GT) and perhaps also in patients receiving alpha(IIb)beta(3) inhibitors is the administration of recombinant factor Vila (rFVIIa). The mechanism of action of rFVIIa in these patients is, however, still unclear. We studied the effect of rFVIIa-mediated thrombin formation on adhesion of alpha(IIb)beta(3)-deficient platelets under flow conditions. Adhesion of alpha(IIb)beta(3)-deficient platelets to the extracellular matrix (ECM) of stimulated human umbilical vein endothelial cells or to collagen type III was studied using a model system with washed platelets and red cells. When alpha(IIb)beta(3)-deficient platelets were perfused over the surface at arterial shear rate for 5 minutes, a low surface coverage was observed (GT platelets, mean +/- SEM, 37.5% +/- 5.0%; normal platelets preincubated with an RGD-containing peptide, 7.4% +/- 2.1%). When rFVIIa, together with factors X and II, was added to the perfusate, platelet deposition significantly increased (GT platelets, mean SEM, 67.0% +/- 4.3%; normal platelets preincubated with an RGD-containing peptide, 48.2% +/- 2.9%). The same effect was observed when normal platelets were pretreated with the commercially available anti-alpha(IIb)beta(3) drugs abciximab, eptifibatide, or tirofiban. It was shown that tissue factor-independent thrombin generation (presumably induced by binding of rFVIIa to adhered platelets) was responsible for the increase in platelet deposition. In conclusion, defective adhesion of alpha(IIb)beta(3)-deficient platelets to ECM can be restored by tissue factor-independent rFVIIa-mediated thrombin formation. The enhanced generation of platelet procoagulant surface facilitates fibrin formation, so that lack of platelet aggregate formation might be compensated for.
引用
收藏
页码:1864 / 1870
页数:7
相关论文
共 34 条
[1]   Recombinant factor VIIa corrects prothrombin time in cirrhotic patients: A preliminary study [J].
Bernstein, DE ;
Jeffers, L ;
Erhardtsen, E ;
Reddy, KR ;
Glazer, S ;
Squiban, P ;
Bech, R ;
Hedner, U ;
Schiff, ER .
GASTROENTEROLOGY, 1997, 113 (06) :1930-1937
[2]  
Coller BS, 2001, THROMB HAEMOSTASIS, V86, P427
[3]   Binding of thrombin to glycoprotein Ib accelerates the hydrolysis of Par-1 on intact platelets [J].
De Candia, E ;
Hall, SW ;
Rutella, S ;
Landolfi, R ;
Andrews, RK ;
De Cristofaro, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (07) :4692-4698
[4]  
DEMARCO L, 1994, J BIOL CHEM, V269, P6478
[5]   The GPIb thrombin-binding site is essential for thrombin-induced platelet procoagulant activity [J].
Dörmann, D ;
Clemetson, KJ ;
Kehrel, BE .
BLOOD, 2000, 96 (07) :2469-2478
[6]   Platelet glycoprotein IIb/IIIa receptors and Glanzmann's thrombasthenia [J].
French, DL ;
Seligsohn, U .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (03) :607-610
[7]   The effect of the administration of recombinant activated factor VII (NovoSeven®) on perioperative blood loss in patients undergoing transabdominal retropubic prostatectomy:: the PROSE study [J].
Friederich, PW ;
Geerdink, MGF ;
Spataro, M ;
Messelink, EJ ;
Henny, CP ;
Büller, HR ;
Levi, M .
BLOOD COAGULATION & FIBRINOLYSIS, 2000, 11 :S129-S132
[8]  
GALAN AM, 2001, THROMB HAEMOST, V88
[9]  
HACKENG TM, 1994, J BIOL CHEM, V269, P21051
[10]  
HEDNER U, 1988, LANCET, V2, P1193